MedTrace Logo

mRNA Expression in Lymphocytes of Glaucoma Patients

NCT00327509 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2009-08-20

No results posted yet for this study

Summary

The aim of the study is to compare messenger ribonucleic acid (mRNA) expression of various genes in lymphocytes between glaucoma patients and sex and age-matched healthy subjects. A secondary objective is to analyze the impact of different forms of glaucoma or of a vasospastic propensity on the findings.

Conditions

Sponsors & Collaborators

  • University of Bonn

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Selim Orgül, MD · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00327509 on ClinicalTrials.gov